How KYMRIAH May Help
Relapsed/refractory (r/r) B-cell acute lymphoblastic leukemia (ALL) treatment, individualized just for you
At Month 3, more than 8 out of 10 (52 out of 63) patients treated with KYMRIAH went into remission.
Refractory, your cancer did not respond to treatment; Relapsed, your cancer has returned; Remission, the signs of your cancer have disappeared or else your disease is under control. It does not necessarily mean a cure.
